We are live on
!
Find out more
PVI
Pura Vida Investments Portfolio holdings
AUM
$14.9M
1-Year Est. Return
38.76%
This Fund
S&P 500
This Quarter
Est. Return
+1.53%
1 Year Est. Return
+38.76%
3 Year Est. Return
+26.8%
5 Year Est. Return
+25.03%
10 Year Est. Return
+1,723.84%
AUM
$988M
AUM Growth
-$950M
(-49%)
Cap. Flow
-$941M
Cap. Flow
% of AUM
-95.22%
Top 10 Holdings %
Top 10 Hldgs %
46.58%
Holding
205
New
16
Increased
16
Reduced
38
Closed
131
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Quanterix
QTRX
|
+$23.5M |
| 2 |
Outset Medical
OM
|
+$11.4M |
| 3 |
LivaNova
LIVN
|
+$8.76M |
| 4 |
CUTR
Cutera, Inc.
CUTR
|
+$5.89M |
| 5 |
RCM
R1 RCM Inc. Common Stock
RCM
|
+$4.31M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Inspire Medical Systems
INSP
|
+$26.8M |
| 2 |
ISEE
IVERIC bio, Inc. Common Stock
ISEE
|
+$25.3M |
| 3 |
Biogen
BIIB
|
+$17.4M |
| 4 |
Establishment Labs
ESTA
|
+$15.9M |
| 5 |
VRAY
ViewRay, Inc.
VRAY
|
+$14.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 31.61% |
| 2 | Industrials | 1.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
126
Incyte
INCY
$24.5B
| – | – |
-30,400
| Closed | -$2.44M |
|
127
CALL
iRhythm Holdings
IRTC
$4.13B
| – | – |
-70,000
| Closed | -$6.56M |
|
128
Intuitive Surgical
ISRG
$142B
| – | – |
-10,000
| Closed | -$2.46M |
|
|
KALV
129
DELISTED
KalVista Pharmaceuticals
KALV
| – | – |
-732,702
| Closed | -$4.95M |
|
130
Lantheus
LNTH
$6.57B
| – | – |
-116,665
| Closed | -$7.52M |
|
131
Liquidia Corp
LQDA
$7.01B
| – | – |
-208,535
| Closed | -$1.33M |
|
132
CALL
Pulmonx
LUNG
$98.4M
| – | – |
-100,000
| Closed | -$843K |
|
133
PUT
Madrigal Pharmaceuticals
MDGL
$12.4B
| – | – |
-36,000
| Closed | -$10.4M |
|
134
PUT
Medtronic
MDT
$116B
| – | – |
-130,000
| Closed | -$10.1M |
|
135
Milestone Pharmaceuticals
MIST
$141M
| – | – |
-371,788
| Closed | -$1.47M |
|
|
NUVL
136
DELISTED
Nuvalent
NUVL
| – | – |
-70,523
| Closed | -$2.1M |
|
137
CALL
NovoCure
NVCR
$2.05B
| – | – |
-35,000
| Closed | -$2.57M |
|
|
138
NovoCure
NVCR
$2.05B
| – | – |
-50,000
| Closed | -$3.67M |
|
|
139
PUT
NovoCure
NVCR
$2.05B
| – | – |
-265,100
| Closed | -$19.4M |
|
|
140
CALL
Outset Medical
OM
$84.6M
| – | – |
-25,053
| Closed | -$9.7M |
|
141
CALL
Oramed Pharmaceuticals
ORMP
$178M
| – | – |
-185,500
| Closed | -$2.23M |
|
142
Pacific Biosciences
PACB
$345M
| – | – |
-100,000
| Closed | -$818K |
|
143
Vaxcyte
PCVX
$8.88B
| – | – |
-61,528
| Closed | -$2.95M |
|
144
CALL
Penumbra
PEN
$12.9B
| – | – |
-41,900
| Closed | -$9.32M |
|
145
CALL
Pfizer
PFE
$150B
| – | – |
-100,000
| Closed | -$5.12M |
|
146
Prothena Corp
PRTA
$475M
| – | – |
-64,000
| Closed | -$3.86M |
|
147
CALL
Privia Health
PRVA
$2.75B
| – | – |
-350,000
| Closed | -$7.95M |
|
148
Qiagen
QGEN
$8.88B
| – | – |
-10,374
| Closed | -$549K |
|
|
149
CALL
Quanterix
QTRX
$139M
| – | – |
-1,105,800
| Closed | -$15.3M |
|
150
PUT
Rocket Pharmaceuticals
RCKT
$374M
| – | – |
-150,000
| Closed | -$2.94M |
|
Similar funds
BCA
RC
DOFI
SCI
LPC
GBCP
SCTC
M
Pura Vida Investments's Q1 2023 Portfolio in Review
As of Q1 2023, Pura Vida Investments held 205 positions worth $988M, down 49% from $1.94B the previous quarter. Its ten largest holdings account for 47% of the portfolio.
Pura Vida Investments withdrew a net $941M in Q1 2023, closing 131 positions and reducing 38 holdings. Its most notable exit was IVERIC bio, Inc. Common Stock, an estimated $25.3M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 32% of assets, up from 27% a quarter earlier, followed by Industrials.
Against the trend, Pura Vida Investments opened a new position in Repligen worth $2.56M.
- Pura Vida Investments's largest Q1 2023 buy was Repligen: 15,200 shares worth $2.56M.
- Pura Vida Investments added most to Quanterix in Q1 2023, an estimated $23.5M increase.
- Pura Vida Investments's biggest Q1 2023 reduction was Inspire Medical Systems, cutting an estimated $26.8M.
- Pura Vida Investments fully exited IVERIC bio, Inc. Common Stock in Q1 2023, selling an estimated $25.3M.
- Pura Vida Investments's ten largest holdings make up 47% of its $988M portfolio in Q1 2023.
- Pura Vida Investments opened 16 new positions and closed 131 in Q1 2023.
- Pura Vida Investments's portfolio value fell 49% quarter-over-quarter to $988M.
Based on Pura Vida Investments's 13F filing for Q1 2023, filed 15 May 2023.